Associate Professor, Dermatology, University of Minnesota Medical School

Dermatology

Doctor Daniel H. Kaplan, MD works in the field of Dermatology. He attended Washington University School of Medicine in St. Louis. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAD)". Daniel H. Kaplan is a published doctor and has 39 publications published. The lastest was: 'Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.' He accepts all Medicare patients.

Publications

---

• Skin dendritic Cells induce follicular helper T Cells and protective humoral immune responses.
• Selective programming of CCR10(+) innate lymphoid Cells in skin-draining lymph nodes for cutaneous homeostatic regulation.
• Candida albicans Morphology and Dendritic Cell Subsets Determine T Helper Cell Differentiation.
• The NF-κB regulator Bcl-3 modulates inflammation during contact hypersensitivity reactions in radioresistant Cells.
• Low-Dose Interleukin 2 to Reverse Alopecia Areata.
• Targeting Antigens through Blood Dendritic Cell Antigen 2 on Plasmacytoid Dendritic Cells Promotes Immunologic Tolerance.
• Intestinal lamina propria dendritic Cells maintain T Cell homeostasis but do not affect commensalism.
• The IL-20 cytokine subfamily: bad guys in host defense?
• Autocrine/paracrine TGF-β1 inhibits Langerhans Cell migration.
• Langerhans Cells Require MyD88-Dependent Signals for Candida albicans Response but Not for Contact Hypersensitivity or Migration.
• Early immune events in the induction of allergic contact Dermatitis.
• Langerhans Cells facilitate epithelial DNA damage and squamous Cell carcinoma.
• Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell Responses.
• Characterization of langerin-expressing dendritic Cell subsets in the normal cornea.
• Protective T Cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.
• Langerhans Cells are not required for epidermal V{gamma}3 T Cell homeostasis and function.
• Langerhans Cells are not required for graft-versus-host disease.
• Dendritic Cells in lupus are not required for activation of T and B Cells but promote their expansion, resulting in tissue damage.
• Acute ablation of Langerhans Cells enhances skin immune responses.
• Langerhans Cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans Cell-derived IL-10.
• Langerhans Cell deficiency impairs Ixodes scapularis suppression of Th1 responses in mice.
• Langerhans Cells are not required for efficient skin graft rejection.
• Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.
• Identification of a novel population of Langerin+ dendritic Cells.
• Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans Cells.
• Cutaneous myiasis associated with scalp Psoriasis.
• Epidermal langerhans Cell-deficient mice develop enhanced contact hypersensitivity.
• Target antigens determine graft-versus-host disease phenotype.
• Immune mediated shaping of microflora community composition depends on barrier site.
• Association between biologic therapies for chronic plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.
• Holiday hazards: common stings from New World visits.
• Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
• Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.
• Plasmacytoid dendritic Cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
• Insights into Langerhans Cell function from Langerhans Cell ablation models.
• The evolving function of Langerhans Cells in adaptive skin immunity.
• Langerhans Cells: not your average dendritic Cell.
• In vivo function of Langerhans Cells and dermal dendritic Cells.

Schools

---

• Washington Center School of Medicine

• Beth Israel Deaconess Med Center

• Yale New Haven Hospital

Procedures Preformed

---

• Destruction of Benign Skin Lesion
• Destruction of Malignant Skin Lesion
• Excision of Malignant Skin Lesion
• Skin Tag Removal

Conditions Treated

---

• Acne
• Actinic Keratosis
• Athlete's Foot
• Atopic Dermatitis (Eczema)
• View All

Doctors Specialties

---

• Dermatology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Fellow (FAAD)

Education

---

• Yale-New Haven Hospital
• Beth Israel Deaconess Medical Center
• Washington University School of Medicine in St. Louis

Hospital

---

• University of Minnesota Medical Center, Fairview

Drug Facts

---

NPI NUMBER		1407847890
NPPES Provider LastName		KAPLAN
NPPES Provider FirstName		DANIEL
NPPES Provider ZIPCode		554550341
NPPES Provider State		MN
Specialty Description		Dermatology
Total Claim Count		141.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1407847890
Last Name Of The Provider	KAPLAN
First Name Of The Provider	DANIEL
View All

Similar Doctors

---

	Dr. Elyse H. Scheuer, MD This Doctor is OpenDoctor Recommended.
	Dr. Caleb H. Creswell, MD This Doctor is OpenDoctor Recommended.
	Dr. H Spencer Holmes, MD
	Dr. Neal A. Foman, MD This Doctor is OpenDoctor Recommended.
	Dr. Scott P. Prawer, MD This Doctor is OpenDoctor Recommended.
	Dr. Kimberly A. Bohjanen, MD This Doctor is OpenDoctor Recommended.
	Dr. Matthew W. Tsang, MD This Doctor is OpenDoctor Recommended.
	Dr. Lauren R. Becker, MD
	Dr. Jaime L. Davis, MD
	Dr. Mitchell E. Bender, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael M. MacAulay, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul C. Jou, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog